CA 19-9 level in different T stages, grades, depth of invasion, and in... | Download Scientific Diagram
CA-19-9 - Diagnostic Kit
Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer
The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells | Scientific Reports
Cancers | Free Full-Text | Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application
Frontiers | Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy
Lewis antigen‑negative pancreatic cancer: An aggressive subgroup
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter - ScienceDirect
Cancers | Free Full-Text | Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors
Patients with CA 19-9 > 37 U/ml in different tumor grades, depth of... | Download Scientific Diagram
CA 19-9 Antigen - an overview | ScienceDirect Topics
Multivariate Analysis: Lewis Antigen Negative v CA 19-9 180 v CA 19-9 180 | Download Table
Biomolecular recognition of the glycan neoantigen CA19-9 by distinct antibodies | bioRxiv
Post-Resection CA 19-9 Predicts Overall Survival in Patients Treated with Adjuvant Chemoradiation; RTOG 9704 A. Berger, K. Winter, J. Hoffman, W. Regine, - ppt download
Elevation of CA19-9-Related Novel Marker, Core 1 Sialyl Lewis A, in Sera of Adenocarcinoma Patients Verified by a SRM-Based Method | Journal of Proteome Research